“SAFETY, TOLERABILITY AND BIOEQUIVALENCE ASSESSMENT OF A DISPERSIBLE TABLET FORMULATION OF PYRAZINAMIDE”. 2017. International Journal of Pharmaceutical Sciences and Drug Research 9 (5): 220-23. https://doi.org/10.25004/IJPSDR.2017.090503.